A vicious loop involving RET signaling might influence cell survival and resistance to therapy in ER+ BC: the estrogen-induced upregulation of RET and ARTN promote tumorigenesis by recruiting inflammatory cells that can, on their side, induce GDNF. This evidence concerns the gene RET and breast cancer.